Literature DB >> 32392377

COVID-19: Generate and apply local modelled transmission and morbidity effects to provide an estimate of the variation in overall relative healthcare resource impact at general practice granularity.

Mike Stedman1, Mark Lunt2, Mark Davies1, Martin Gibson3, Adrian Heald2,3.   

Abstract

INTRODUCTION: Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the name given to the 2019 novel coronavirus. COVID-19 is the name given to the disease associated with the virus. SARS-CoV-2 is a new strain of coronavirus not been previously identified in humans.
METHODS: Two key factors, case incidence and case morbidity, were analysed for England. When taken together they give an estimate of relative demand on healthcare utilisation. To analyse case incidence, the latest values for indicators that could be associated with infection transmission rates were collected from the Office of National Statistics (ONS) and Quality Outcome Framework (QOF) sources. These included population density, %age >16, at fulltime work/education, %age over 60, %BME ethnicity, social deprivation as IMD2019, location as latitude/longitude, and patient engagement as %self-confident in their own long-term condition management. Average case morbidity was calculated. To provide a comparative measure of overall healthcare resource impact, individual GP practice impact scores were compared against the median practice.
RESULTS: The case incidence regression is a dynamic situation but it currently shows that Urban, %Working, and age >60 were the strongest determinants of case incidence. The local population comorbidity remains unchanged. The range of relative healthcare impact was wide with 80% of practices falling at 20%-250% of the national median. Once practice population numbers were included we found that the top 33% of GP practices supporting 45% of the patient population would require 68% of COVID-19 healthcare resources. The model provides useful information about the relative impact of Covid-19 on healthcare workload at GP practice granularity in all parts of England.
CONCLUSION: Covid-19 is impacting on the utilisation of health/social care resources across the world. This model provides a way of predicting relative local levels of disease burden based on defined criteria, thereby providing a method for targeting limited care resources to optimise national/regional/local responses to the COVID-19 outbreak.
© 2020 The Authors. International Journal of Clinical Practice published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32392377     DOI: 10.1111/ijcp.13533

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

1.  Virtual Coaching Delivered by Pharmacists to Prevent COVID-19 Transmission.

Authors:  Derar H Abdel-Qader; Ahmad Z Al Meslamani; Nadia Al Mazrouei; Asma A El-Shara; Husam El Sharu; Eman Merghani Ali; Samah Bahy Mohammed Ebaed; Osama Mohamed Ibrahim
Journal:  Hosp Pharm       Date:  2021-07-10

2.  Distress and Living with Diabetes: Defining Characteristics Through an Online Survey.

Authors:  Unaiza Waheed; Adrian H Heald; Mike Stedman; Emma Solomon; Rustam Rea; Saydah Eltom; J Martin Gibson; Katherine Grady; Arie Nouwen; Gerry Rayman; Angela Paisley
Journal:  Diabetes Ther       Date:  2022-07-13       Impact factor: 3.595

3.  Academic general practice/family medicine in times of COVID-19 - Perspective of WONCA Europe.

Authors:  Adam Windak; Thomas Frese; Eva Hummers; Zalika Klemenc Ketis; Sonia Tsukagoshi; Josep Vilaseca; Shlomo Vinker; Mehmet Ungan
Journal:  Eur J Gen Pract       Date:  2020-12       Impact factor: 1.904

4.  Impact of COVID-19 on workload burden of a complex radiotherapy facility.

Authors:  Giulio Francolini; Isacco Desideri; Giulia Stocchi; Lucia Pia Ciccone; Viola Salvestrini; Pietro Garlatti; Michele Aquilano; Daniela Greto; Pierluigi Bonomo; Icro Meattini; Vieri Scotti; Silvia Scoccianti; Gabriele Simontacchi; Lorenzo Livi
Journal:  Radiol Med       Date:  2021-03-01       Impact factor: 3.469

5.  Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis.

Authors:  David Holland; Adrian H Heald; Mike Stedman; Fahmy Hanna; Pensee Wu; Christopher Duff; Lewis Green; Sarah Robinson; Ian Halsall; Neil Gaskell; John Pemberton; Christine Bloor; Anthony A Fryer
Journal:  J Clin Pathol       Date:  2021-10-13       Impact factor: 3.411

6.  A phased approach to unlocking during the COVID-19 pandemic-Lessons from trend analysis.

Authors:  Mike Stedman; Mark Davies; Mark Lunt; Arpana Verma; Simon G Anderson; Adrian H Heald
Journal:  Int J Clin Pract       Date:  2020-05-19       Impact factor: 3.149

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.